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ABSTRACT 
 
The first use of microalgae by humans dates back 2000 years to the Chinese, who used 
Nostoc to survive during famine. However, microalgal biotechnology only really began to 
develop in the middle of the last century. Nowadays, there are numerous commercial 
applications of microalgae. For example, (1) microalgae can be used to enhance the nutritional 
value of food and animal feed owing to their chemical composition, (2) they play a crucial 
role in aquaculture and (3) they can be incorporated into cosmetics. Moreover, they are 
cultivated as a source of highly valuable molecules. For example, polyunsaturated fatty acid 
oils are added to infant formulas and nutritional supplements and pigments are important as 
natural dyes. Stable isotope biochemicals help in structural determination and metabolic 
studies. Future research should focus on the improvement of production systems and the 
genetic modification of strains. Microalgal products would in that way become even more 
diversified and economically competitive. 
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INTRODUCTION 
 
Microalgal use by indigenous populations has occurred for centuries. Indeed, edible 
blue-green algae including Nostoc, Arthrospira (Spirulina) and Aphanizomenon species have 
been used for food for thousands of years (1). However, the cultivation of microalgae is only a 
few decades old (2). 
In the early 1950’s, the increase in the world’s population and predictions of an 
insufficient protein supply led to a search for new alternative and unconventional protein 
sources. Algal biomass appeared at that time as a good candidate for this purpose (3, 4). 
Meanwhile, the systematic examination of algae for biologically active substances, 
particularly antibiotics, began (5). 
Interest in applied algal culture continued with studies of the use of algae as 
photosynthetic gas exchangers for space travel (2). In the USA, environmental technologies 
aimed at the improvement in the quality of wastewater and the fermentation of the resulting 
biomass to methane were implemented (6). This use of microalgae for generating renewable 
energy sources provoked heightened interest during the energy crisis in the 1970’s (4, 6, 7). 
Commercial large-scale culture started in the early 1960’s in Japan with the culture of 
Chlorella by Nihon Chlorella (Taipei, Taiwan) (2, 8, 9). It was followed in the early 1970’s by 
the establishment of an Arthrospira harvesting and culturing facility in Lake Texcoco by Sosa 
Texcoco S.A. (Mexico City, Mexico) (2, 8). The first aquaculture fields also appeared in the 
1970’s (6). 
By 1980, there were 46 large-scale factories in Asia producing more than 1000 kg of 
microalgae (mainly Chlorella) per month. The commercial production of Dunaliella salina, as 
a source of β-carotene, became the third major microalgal industry when production facilities 
were established by Western Biotechnology (Hutt Lagoon, Australia) and Betatene (Whyalla, 
Australia) (now Cognis Nutrition and Health) in 1986. These were soon followed by other 
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commercial plants in Israel and the USA. The same as that of these algae, the large-scale 
production of cyanobacteria (blue-green algae) began in India at about the same time. More 
recently, several plants producing Haematococcus pluvialis as a source of astaxanthin have 
been established in the USA and India (Biotechnological and Environmental Applications of 
microalgae (BEAM), an Australian Research Network. Official web page. 
wwwscieng.murdoch.edu.au/centres/algae/BEAM-Net/BEAM-Appl0.htm, 2005). Thus, in a 
short period of about 30 years, the microalgal biotechnology industry has grown and 
diversified significantly. Nowadays, the microalgal biomass market produces about 5000 t of 
dry matter/year and generates a turnover of approximately US$ 1.25×109/year (processed 
products not included in this figure) (10). 
The aim of this study is to summarize the commercial applications of microalgae. As 
history has shown, research studies on microalgae have been numerous and varied but they 
have not always resulted in commercial applications. Although recent reviews on microalgal 
applications exist, they generally mix actual applications and future potential developments. 
Thus, our purpose is to clarify the actual situation by only discussing real commercial 
applications and to illustrate them with examples of microalgal manufacturers and 
commercialized products. Therefore, in the first part, the chemical composition of microalgae, 
on which a majority of applications are based, is presented in detail. Then, the use of 
microalgae for human and animal nutrition is presented. Finally, the applications of 
microalgae in cosmetics and high-value molecules extracted from these microorganisms are 
reviewed. 
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CHEMICAL COMPOSITION OF MICROALGAE 
 
Microalgae are able to enhance the nutritional content of conventional food 
preparations and hence, to positively affect the health of humans and animals. This is due to 
their original chemical composition. Table 1 presents a comparison of the general 
compositions of human food sources with that of different algae.  
The high protein content of various microalgal species is one of the main reasons to 
consider them as an unconventional source of protein (4, 11). In addition, the amino acid 
pattern of almost all algae compares favorably with that of other food proteins. As the cells are 
capable of synthesizing all amino acids, they can provide the essential ones to humans and 
animals (12). However, to completely characterize the protein and determine the amino acid 
content of microalgae, information on the nutritive value of the protein and the degree of 
availability of amino acids should be given (13). Carbohydrates in microlagae can be found in 
the form of starch, glucose, sugars and other polysaccharides. Their overall digestibility is 
high, which is why there is no limitation to using dried whole microalgae in foods or feeds 
(3). The average lipid content of algal cells varies between 1% and 70% but can reach 90% of 
dry weight under certain conditions (14). Algal lipids are composed of glycerol, sugars or 
bases esterified to saturated or unsaturated fatty acids (12 to 22 carbon atoms). Among all the 
fatty acids in microalgae, some fatty acids of the ω3 and ω6 families are of particular interest. 
The total amount and relative proportion of fatty acids can be affected by nutritional and 
environmental factors, nitrogen limitation, for example (15-18). Microalgae also represent a 
valuable source of nearly all essential vitamins (e.g., A, B1, B2, B6, B12, C, E, nicotinate, biotin, 
folic acid and pantothenic acid) (3). Vitamins improve the nutritional value of algal cells but 
their quantity fluctuates with environmental factors, the harvesting treatment and the method 
of drying the cells (19, 20). Microalgae are also rich in pigments like chlorophyll (0.5% to 1% 
of dry weight), carotenoids (0.1% to 0.2% of dry weight on average and up to 14% of dry 
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weight for β-carotene of Dunaliella) and phycobiliproteins. These molecules have a wide 
range of commercial applications (as detailed below). 
Thus, their composition gives microalgae interesting qualities, which can be applied in 
human and animal nutrition. However, prior to commercialization, algal material must be 
analyzed for the presence of toxic compounds to prove their harmlessness (21, 22). In this 
domain, recommendations have been published by different international organizations and 
additional national regulations often exist. They concern nucleic acids, toxins and heavy-metal 
components. Concerning nucleic acid toxicity, the safe level is about 20 g of algae per day or 
0.3 g of algae per kg of body weight (3, 13). Finally, many metabolic studies have confirmed 
the capacities of microalgae as a novel source of protein: the average quality of most of the 
algae examined is equal or even superior to that of other conventional high-quality plant 
proteins (3). 
 
 
MICROALGAE IN HUMAN AND ANIMAL NUTRITION 
 
Human nutrition  Microalgae for human nutrition are nowadays marketed in different 
forms such as tablets, capsules and liquids. They can also be incorporated into pastas, snack 
foods, candy bars or gums, and beverages (23, 24). Owing to their diverse chemical 
properties, they can act as a nutritional supplement or represent a source of natural food 
colorants (2, 11, 25). The commercial applications are dominated by four strains: Arthrospira, 
Chlorella, D. salina and Aphanizomenon flos-aquae. 
Arthrospira is used in human nutrition because of its high protein content and its 
excellent nutritive value (11, 26-28). In addition, this microalga has various possible health-
promoting effects: the alleviation of hyperlipidemia, suppression of hypertension, protection 
against renal failure, growth promotion of intestinal Lactobacillus, and suppression of 
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elevated serum glucose level (23, 24, 29). A significant amount of Arthrospira production is 
realized in China and India. The world’s largest producer Hainan Simai Enterprising Ltd. is 
located in the Hainan province of China. This company has an annual production of 200 t of 
algal powder, which accounts for 25% of the total national output and almost 10% of the 
world output. The largest plant in the world is owned by Earthrise Farms and streches over an 
area of 440,000 m2 (located at Calipatria, CA, USA; Fig. 1). Their production process is 
presented in Fig. 2. Their Arthrospira-based products (tablets and powder) are distributed in 
over 20 countries around the world. Many other companies sell a wide variety of 
nutraceuticals made from this microalga. For example, the Myanmar Spirulina Factory 
(Yangon, Myanmar) sells tablets, chips, pasta and liquid extract, and Cyanotech Corp. (a plant 
in Kona, Hawaii, USA) produces products ranging from pure powder to packaged bottles 
under the name Spirulina pacifica. Cyanotech Corp. has developed an orginal process for 
drying the biomass in order to avoid the oxidation of carotenes and fatty acids that occurs with 
the use of standard dryers. The patented process employs a closed drying system that is kept at 
low oxygen concentrations by flushing with nitrogen and carbon dioxide. The process relies 
on a very cold ocean water crown from a depht of 600 m just offshore to provide 
dehumidification and actually dries microalgal products in less than 6 s (Fig. 3). 
Chlorella is produced by more than 70 companies; Taiwan Chlorella Manufacturing 
and Co. (Taipei, Taiwan) is the largest producer with 400 t of dried biomass produced per 
year. Significant production is also achieved in Klötze, Germany (130 – 150 t dry biomass per 
year) with a tubular photobioreactor. This reactor consists of compact and vertically arranged 
horizontal running glass tubes with a total length of 500,000 m and a total volume of 700 m3 
(Fig. 4). The world annual sales of Chlorella are in excess of US$ 38 billion (23). The most 
important substance in Chlorella is β-1,3-glucan, which is an active immunostimulator, a 
free-radical scavenger and a reducer of blood lipids (9, Ryll et al., Abstr. Europ. Workshop 
Microalgal Biotechnol., Germany, p. 56, 2003). However, various other health-promoting 
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effects have been clarified (efficacy on gastric ulcers, wounds, and constipation; preventive 
action against atherosclerosis and hypercholesterolemia; and antitumor action) (23, 30). 
Chlorella can also be used as a food additive owing to the taste- and flavour-adjusting actions 
of its coloring agent (23, 31). 
D. salina is exploited for its β-carotene content that can reach 14% of dry weight (14). 
For human consumption, Cognis Nutrition and Health, the world’s largest producer of this 
strain, offers Dunaliella powder as an ingredient of dietary supplements and functional foods. 
The last major commercial strain application is A. flos-aquae. According to many 
research studies, used alone or in combination with other nutraceuticals and natural food 
products, A. flos-aquae promotes good overall health (1, 32, 33). 
 
Animal nutrition  In addition to its use in human nutrition, microalgae can be 
incorporated into the feed for a wide variety of animals ranging from fish (aquaculture) to pets 
and farm animals. In fact, 30% of the current world algal production is sold for animal feed 
applications (3) and over 50% of the current world production of Arthrospira is used as feed 
supplement (23). 
In 1999, the production of microalgae for aquaculture reached 1000 t (62% for 
molluscs, 21% for shrimps, and 16% for fish) for a global world aquaculture production of 
43×106 t of plants and animals (34). The importance of algae in this domain is not surprising 
as they are the natural food source of these animals. The main applications of microalgae for 
aquaculture are associated with nutrition, being used fresh (as sole component or as food 
additive to basic nutrients) for coloring the flesh of salmonids and for inducing other 
biological activities. 
Microalgae are required for larval nutrition during a brief period, either for direct 
consumption in the case of molluscs and peneid shrimp or indirectly as food for the live prey 
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fed to small fish larvae (16, 35). The most frequently used species are Chlorella, Tetraselmis, 
Isochrysis, Pavlova, Phaeodactylum, Chaetoceros, Nannochloropsis, Skeletonema and 
Thalassiosira (23, 25, 35, 36). In order to be used in aquaculture, a microalgal strain has to 
meet various criteria. It has to be easily cultured and nontoxic. It also needs to be of the 
correct size and shape to be ingested and to have a high nutritional qualities and a digestible 
cellwall to make nutrients available (19, 37). Protein content is a major factor determining the 
nutritional value of microalgae. In addition, highly unsaturated fatty acid (e.g., 
eicosapentaenoic acid (EPA), arachidonic acid (AA) and docosahexaenoic acid (DHA)) 
content is of major importance (38). Indeed, some fatty acids are essential for many marine 
animals (39) and similar requirements exist for the growth and metamorphosis of many larvae 
(40, 41). However, it should be noted that the ratios of DHA, EPA and AA may be more 
important than their absolute levels (25). Microalgal vitamin content also has to be taken into 
account as it may be equally important (19, 23). 
To provide more better balanced nutrition and improve animal growth, several reports 
advise mixing species from the ones listed above. This gives better results than a diet 
composed of only one algal species (23, 40). 
While microalgae provide food for zooplanktons, they also help to stabilize and 
improve the quality of the culture medium. Indeed, for numerous freshwater and seawater 
animal species, the introduction of phytoplanktons to rearing ponds (green-water technique) 
leads to much better results in terms of survival, growth and transformation index than that of 
the clear-water technique (42-44). The reasons for this are not entirely known but may include 
(34, 35) water quality improvement and stabilization by algal oxygen production and pH 
stabilization, the action of some excreted biochemical compounds along with the induction of 
behavioral processes like initial prey catching, and the regulation of bacterial population, 
probiotic effects (45), and the stimulation of immunity (suggested but not sufficiently 
understood). 
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Microalgae are also used to refine the products of aquaculture. In fact, artificial diets 
lack natural sources of pigments that give organisms such as salmon and trout their 
characteristic coloration. Thus, carotenoid pigments like astaxanthin must be supplied in these 
diets (25, 29, 46). Although a large majority of the astaxanthin market (95%) focuses on the 
synthetic form, Haematococcus algae can also be used as a natural food colorant (47). In fact, 
microalgal astaxanthin has been approved in Japan and Canada as pigment in salmonid feeds 
(48). Feeds including 5% to 20% Arthrospira (rich in carotene pigments), which enhances the 
red and yellow patterns in carp, while leaving a brilliant white color. This clarity and color 
definition increase their value (Resource center for Spirulina and microalgae. Official web 
page. http://www.spirulinasource.com, 2005). Another example is the traditional French 
technique called the greening of oysters. It consists of creating a blue-green color on the gills 
and labial palps of oysters using the diatom Haslea ostrearia. This increases the product’s 
market value by 40% (35). 
Nevertheless, despite the advantages of live microalgae in aquaculture, the current 
trend is to avoid using them. This is due to their high cost and the difficulty in producing, 
concentrating and storing them (36, 40). As a result, diets replacements for live algae have 
been developed (e.g., yeasts, microencapsulated diet, and preserved algae). For example, in 
Japan, where Nannochloropsis oculata is the most important cultured feed for the rotifer 
Brachionus plicatilis, concentrated suspensions and frozen biomass of this microalga are 
commercially available (49). The partial replacement of live algae with microencapsulated 
and yeast-based diets is now routine in hatcheries for peneid shrimp (50). The presently 
available pastes cost at least US$ 160 and more per kg dry weight (personnal communication). 
In marine fish hatcheries, the tendency is to apply the clear-water technique instead of the 
green-water technique. Nevertheless, the omission of algae from the larval tanks often results 
in a less-predictable culture performance. New solutions for totally replacing microalgae in 
aquaculture diets are not yet sufficiently advanced to enable widespread adoption (35, 36). 
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Animal feed (pets and farming)  Many nutritional and toxicological evaluations have 
proved the suitability of algal biomass as feed supplement (3). Arthrospira is largely used in 
this domain and concerns many types of animal: cats, dogs, aquarium fish, ornamental birds, 
horses, cows and breeding bulls. Algae positively affect the physiology (by providing a large 
profile of natural vitamins, minerals, and essential fatty acids; improved immune response and 
fertility; and better weight control) and their external appearance (resulting in healthy skin and 
a lustrous coat) of animals (52). In poultry rations, algae up to a level of 5-10% can be used 
safely as partial replacement for conventional proteins. Prolonged feeding of algae at higher 
concentrations produces adverse effects. The yellow color of broiler skin and shanks as well 
as of egg yolk is the most important characteristic that can be influenced by feeding algae (3). 
Moreover, the Institut für Getreideverarbeitung (Bergholz-Rehbrücke, Germany) produces a 
natural feed with the algae Chlorella and Arthrospira called Algrow. 
 
 
MICROALGAE IN COSMETICS 
 
Some microalgal species are established in the skin care market, the main ones being 
Arthrospira and Chlorella (51). Some cosmeticians have even invested in their own 
microalgal production system (LVMH, Paris, France and Daniel Jouvance, Carnac, France). 
Microalgae extracts can be mainly found in face and skin care products (e.g., anti-aging 
cream, refreshing or regenerant care products, emollient and as an anti-irritant in peelers). 
Microalgae are also represented in sun protection and hair care products. Here are two 
examples of commercially available products and their properties claimed by their companies; 
a protein-rich extract from Arthrospira repairs the signs of early skin aging, exerts a tightening 
effect and prevents stria formation (Protulines, Exsymol S.A.M., Monaco); and an extract 
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from Chlorella vulgaris stimulates collagen synthesis in skin, thereby supporting tissue 
regeneration and wrinkle reduction (Dermochlorella, Codif, St. Malo, France). 
Recently, two new products have been launched by Pentapharm LTD (Basel, 
Switzerland) (51): an ingredient from Nannochloropsis oculata with excellent skin-tightening 
properties (short and long-term effects) (Pepha-Tight) and an ingredient from D. salina, which 
shows the ability to markedly stimulate cell proliferation and turnover and to positively 
influence the energy metabolism of skin (Pepha-Ctive). 
 
 
HIGH-VALUE MOLECULES 
 
Owing to their global composition, microalgae are generally used in the field of human 
and animal nutrition. However, pure molecules can also be extracted when their 
concentrations are sufficiently high. This leads to valuable products like fatty acids, pigments 
and stable isotope biochemicals. 
 
Fatty acids  Higher plants and animals lack the requisite enzymes to synthesize 
polyunsaturated fatty acids (PUFAs) of more than 18 carbons (52, 53). Thus, they have to get 
them from their food. Fish and fish oil are the common sources of long-chain PUFAs but 
safety issues have been raised because of the possible accumulation of toxins in fish (25). 
Moreover, the application of fish oil as food additive is limited due to problems associated 
with its typical fishy smell, unpleasant taste and poor oxidative stability (52, 54, 55). For 
certain applications, fish oil is not suitable because of the presence of mixed fatty acids (56). 
As PUFAs are found in fish originating from microalgae consumed in oceanic environments, 
it is logical to consider microalgae as potential sources of PUFAs (57). 
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Table 2 presents the microalgal PUFAs of particular interest: however, currently, DHA 
is the only algal PUFA commercially available. Indeed, even if species have demonstrated 
industrial production potential of EPA (Porphyridium purpureum, Phaeodactylum 
tricornutum, Isochrysis galbana, Nannochloropsis sp. and Nitzschia laevis) (49, 56, 58, 59), 
no purified algal oil is currently economically competitive with other sources (25, 49, 60). The 
same problem exist with γ-linolenic acid (GLA) and AA. 
DHA is an ω3 fatty acid found in tissues throughout the body. It is a major structural 
fatty acid in the grey matter of the brain and in the retina of the eye, and is a key component of 
the heart tissue. DHA is important for correct brain and eye development in infants and has 
been shown to support cardiovascular health in adults (61, 62). It is found in a limited 
selection of foods such as fatty fish and organic meat; it also occurs naturally in breast milk 
but is absent from cow’s milk. From 1990 onwards, a number of health and nutrition 
organizations specifically recommended the inclusion of DHA in infant formula for preterm 
and fullterm infants. The world wholesale market for infant formula is now estimated to be 
about US$ 10 billion per annum (62). Martek’s DHA oil for this application (DHASCO, 
Columbia, MD, USA) comes from Crypthecodinium cohnii and contains 40-50% DHA but no 
EPA or other long-chain PUFAs (57, 62, 63). The heterotrophic process uses a number of 
fermenters, each about 100 m3, and meets strict manufacturing conditions that follow the US 
Food and Drug Administration’s (FDA) current Good Manufacturing Practice (cGMP) 
regulations. The production for 2003 was 240 tons (63) and formulas containing Martek’s oil 
are available in more than 60 countries worldwide (e.g., United Kingdom, Mexico, China, 
United States and most recently, Canada). 
Moreover, OmegaTech (USA), also owned by Martek, exploits Schizochytrium to 
produce a low-cost oil formerly known as DHA Gold (10 t in 2003; 63). The oil is currently 
used as an adult dietary supplement in food and beverages, health foods, animal feeds and 
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maricultural products. Example foods are cheeses, yogurts, spreads and dressings, and 
breakfast cereals. Other markets include foods for pregnant and nursing women and 
applications in cardiovascular health (62). 
Finally, the Nutrinova process (Frankfurt, Germany) uses Ulkenia sp. which grows in 80-m3 
fermenters. The oil is sold under the name of DHActive (63, Pulz, Abstr. Europ. Workshop 
Microalgal Biotechnol., Germany, p. 35, 2005). 
 
Pigments  Carotenoids  Among the over 400 known carotenoids, only very few are 
used commercially: β-carotene, astaxanthin (Fig. 5a, b) and, of lesser importance, lutein, 
zeaxanthin, lycopene and bixin (29, 64). Their most important uses are as natural food 
colorants (e.g., orange juice) and as additive for animal feed (poultry, fish). Carotenoids also 
have applications in cosmetics (64). The nutritional and therapeutic relevance of certain 
carotenoids is due to their ability to act as provitamin A, that is, they can be converted into 
vitamin A (65, 66). Moreover, carotenoids have intrinsic anti-inflammatory properties owing 
to their quenching action on relative oxygen species and a therapeutic chemopreventive 
anticancer effect is sometimes attributed to these molecules (46, 64, 66). However, in vitro 
and in vivo investigations in animals and humans have not demonstrated this anticancer effect 
(3). In many markets, microalgal carotenoids are in competition with the synthetic form of the 
pigments. Although the synthetic forms are much less expensive than the natural ones, 
microalgal carotenoids have the advantage of supplying natural isomers in their natural ratio 
(Table 3) (46, 65). It is accepted today that the natural isomer of β-carotene is superior to the 
synthetic all-trans form (3, 26, 29, 48). 
The green halophilic flagellate D. salina is the most suitable organism for the mass 
production of β-carotene since it can produce β-carotene up to 14% of its dry weight (14). It 
can be cultivated outdoors in open ponds owing to the extreme conditions under which it 
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grows (hypersaline, low availability of nitrogen, and high levels of solar radiation). Several 
industrial production plants are operational in Australia, Israel, USA and China (65, 67). The 
major producer of this strain in the world is Cognis Nutrition and Health. Their farms, which 
cover 800 ha, are located at Hutt Lagoon, Western Australia (Fig. 6) and Whyalla, South 
Australia. Three categories of products derive from D. salina: β-carotene extracts, Dunaliella 
powder for human use and dried Dunaliella for feed use. The prices of these products vary 
from US$ 300 to US$ 3000/kg (68). 
Astaxanthin is principally consumed by the salmon feed industry. The annual 
worldwide aquaculture market of this pigment is estimated at US$ 200 million with an 
average price of US$ 2500/kg (69). It is dominated by the synthetic form of the pigment 
which is produced by BASF (Ludwigshafen, Germany) and Hoffman-La Roche (Basel, 
Switzerland) (70). Regarding natural astaxanthin, it is produced by H. pluvialis in a two-stage 
culture process and its concentration can reach 1.5% to 3% of the dry weight (48). The first 
stage is optimized for biomass production (green thin-wall flagellated stage); this is followed 
by an astaxanthin-accumulating stage under intense light conditions and preferably in a 
nutrient-poor medium (thick-walled resting stage). Because of its price, the astaxanthin of H. 
pluvialis cannot compete commercially with the synthetic form in any markets (46). However, 
for few particular applications, natural astaxanthin is preferred. These applications include 
carp, chicken and red sea bream diets. This is due to the enhanced deposition of the natural 
pigment in tissues, regulatory requirements and consumer demand for natural products (71). 
Moreover, since the 1990’s, human nutraceuticals have appeared as a new market possibility 
(46, 47) and Algatech Ltd (Kibbutz Ketura, Israel) sells its product (crushed Haematococcus 
biomass rich in astaxanthin) on the pharmaceutical market (Boussiba, Abstr. Europ. 
Workshop Microalgal Biotechnol., Germany, p. 37, 2003). To lower their costs and compete 
with the synthetic form, their producers plan to expand their production capacity into locales 
with lower land, labor and energy costs such as China (46, 70). 
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Phycobiliproteins  The main commercial producers of phycobiliproteins (i.e., 
phycoerythrin and phycocyanin, Fig. 5c) are the cyanobacterium Arthrospira and the 
rhodophyte Porphyridium (72, 73). The primary potential of these molecules seems to be as 
natural dyes but an increasing number of investigations have shown on their health-promoting 
properties and broad range of pharmaceutical applications. Thus, the first and most important 
application of phycocyanin is as food pigment, replacing current synthetic pigments (3). 
Dainippon Ink & Chemicals (Sakura, Japan) has developed a product called Lina blue which 
is used in chewing gum, ice sherberts, popsicles, candies, soft drinks, dairy products and 
wasabi. They also sell another form of this pigment for natural cosmetics like lipstick and 
eyeliners (23, 72). In addition, phycobiliproteins are widely used in industry and clinical or 
research immunology laboratories. Indeed, their properties (high molar absorbance 
coefficients, high fluorescence quantum yield, large Stokes shift, high oligomer stability and 
high photostability) make them very powerful and highly sensitive fluorescent reagents 
(Prozyme product literature available from 
http://www.prozyme.com/technical/pbvrwdata.html#SPECIFICATIONS, 2005). They can 
serve as labels for antibodies, receptors and other biological molecules in a fluorescence-
activated cell sorter and they are used in immunolabelling experiments and fluorescence 
microscopy or diagnostics (73). The prices of phycobiliproteins products are US$ 3 to US$ 
25/mg for native pigment but they can reach US$ 1500/mg for certain cross-linked pigments 
(with antibodies or other fluorescent molecules, Table 4). Their global market was estimated 
at more than US$ 50 million in 1997 (personnal communication). 
 
Stable isotope biochemicals  Microalgae are ideally suited as a source of stable 
isotopically labeled compounds. The ability to perform photosynthesis allows them to 
incorporate stable isotopes (13C, 15N and 2H) from relatively inexpensive inorganic molecules 
(13CO2, 15NO3, 2H2O) to more highly valued organic compounds (e.g., amino acids, 
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carbohydrates, lipids and nucleic acids). Stable isotope biochemicals are used for two 
purposes (25): incorporation into proteins, carbohydrates and nucleic acids to facilitate their 
structural determination at the atomic level; and metabolic studies exploiting the increased 
mass of compounds labeled. 
Their market is probably higher than US$ 13 million/year (personnal communication). 
Spectra Stable Isotopes (Columbia, MD, USA), a division of Spectra gases (formerly Martek 
Stable Isotope) sells its marked amino acids at prices in the range from US$ 260/g to US$ 
5900/g and its marked nucleic acids at about US$ 28/mg (Table 4). Moreover, it has recently 
developed a process for the autotrophic production of labeled PUFAs from microalgae using 
13CO2, in which 13CO2 is directly sparged into the culture as required. Thus, the carbon loss is 
high and there is a low efficiency of labeled carbon use. In spite of these considerations, this 
company is manufacturing more than 400 g per year of labeled fatty acids at US$ 38,000/g 
(Table 4; 74). 
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CONCLUSION 
 
Some microalgae have been exploited for millenia (Nostoc in China and Arthrospira 
in Chad and Mexico). Currently, they have several applications from human and animal 
nutrition to cosmetics and the production of high-value molecules (e.g., fatty acids, pigments, 
stable isotope biochemicals, Table 5). However, microalgae are still not a well-studied group 
from a biotechnological point of view. Indeed, among the 10,000 species that are believed to 
exist, only a few thousand strains are kept in collections, a few hundred are investigated for 
chemical content and just a handful are cultivated in industrial quantities (i.e., in tons per year) 
(70). The development of microalgal biotechnology has been slowed by the limited growth 
performance of algae in industrial photobioreactors. Currently, the majority of microalgal 
production occurs in outdoor cultivation. However, closed-system commercialization has 
begun with Haematococcus in Japan and Israel and with Chlorella in Germany. Algal 
production systems need to be further improved in order to become more competitive and 
more economically feasible. Heterotrophic and mixotrophic cultivation could be a possible 
avenue of research. The genetic improvement of algal strains is also a present challenge. The 
use of transgenic microalgae for commercial applications has not yet been reported but holds 
significant promise. Modified strains could overproduce traditional or newly discovered algal 
compounds and also serve to express specific genes that cannot be expressed in yeast. This 
could be of great importance for the production of hydrogen, for example. However, a 
successful drug discovery is the most promising aspect of microalgal biotechnology because 
the potential is immense although screening remains limited (75). 
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TABLE 1. General composition of different human food sources and algae (% of dry matter) 
(3) 
Commodity Protein Carbohydrate Lipid 
Bakers’ yeast 39 38 1 
Meat 43 1 34 
Milk 26 38 28 
Rice 8 77 2 
Soybean 37 30 20 
Anabaena cylindrica 43-56 25-30 4-7 
Chlamydomonas rheinhardii 48 17 21 
Chlorella vulgaris 51-58 12-17 14-22 
Dunaliella salina 57 32 6 
Porphyridium cruentum 28-39 40-57 9-14 
Scenedesmus obliquus 50-56 10-17 12-14 
Spirulina maxima 60-71 13-16 6-7 
Synechococcus sp. 63 15 11 
It should be kept in mind that the figures presented in this table are estimaties, since the 
proportion of individual cell constituents largely depends on environmental parameters.
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TABLE 2. Particularly interesting microalgal PUFAs 
PUFA Structure Potential application Microorganism producer 
γ-Linolenic acid (GLA) 18:3 ω6, 9, 12 Infant formulas for full-term infants 
Nutritional supplements 
Arthrospira 
Arachidonic acid (AA) 20:4 ω6, 9, 12 ,15 Infant formulas for full-term/preterm infants 
Nutritional supplements 
Porphyridium  
Eicosapentaenoic acid (EPA) 20:5 ω3, 6, 9, 12, 15 Nutritional supplements 
Aquaculture 
Nannochloropsis, Phaeodactylum, 
Nitzschia 
Docosahexaenoic acid (DHA) 22:6 ω3, 6, 9, 12, 15, 18 Infant formulas for full-term/preterm infants 
Nutritional supplements 
Aquaculture 
Crypthecodinium, Schizochytrium 
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TABLE 3. Comparison between microbial and synthetic sources of carotenoids 
Molecule Origin Isomer Market Price (US$) Principal producer 
Dunaliella All-trans and 9-cis  300 – 3000/kg Cognis Nutrition and Health (Hutt Lagoon and Whyalla, 
Australia), Cyanotech Corp. (Kona, Hawaii, USA), Inner 
Mongolia Biological Eng. Co. (Inner Mongolia, China), 
Nature Beta Technologies (Eilat, Israel), Tianjin Lantai 
Biotechnology (Tianjin, China) 
β-Carotene 
Synthetic All-trans >90%   
Haematococcus 3S, 3’S  
 
Cyanotech Corp. (Kona, Hawaii, USA), Mera 
Pharmaceuticals (Kailua-Kona, Hawaii, USA), Bioreal 
Inc. (Kihei, Hawaii, USA), Parry’s Pharmaceuticals 
(Chennai, India), Algatech Ltd (Kibbutz Ketura, Israel) 
Phaffia yeast 3R, 3’R   DSM (Heerlen, The Netherlands) 
Astaxanthin 
Synthetic 3S, 3’S - 3R, 3’R - 3R, 
3’S (meso) 
>95% ≈ 2500/kg Hoffman La Roche  (Basel, Switzerland) and BASF 
(Ludwigshafen, Germany) 
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TABLE 4. Prices of different products based on microalgal high-value molecules 
Product name Price (US$)  Distributor 
R-phycoerythrin 3.25 – 14/mg Cyanotech Corp. 
Allophycocyanin 6 – 17/mg Cyanotech Corp. 
Streptavidin: B-phycoerythrin 145/mg Martek 
Goat anti-mouse IgG: R-phycoerythrin 165/mg Martek 
SensilightTM PBXL1: anti GST 1500/mg Martek 
Mixed fatty acids 60/g Spectra Stable Isotopes 
13C-mixed free fatty acids 200/g Spectra Stable Isotopes 
13C-DHA (>95%) 38000/g Spectra Stable Isotopes 
15N-alanine 260/g Spectra Stable Isotopes 
2H7, 13C, 15N4-arginine 5900/g Spectra Stable Isotopes 
dATP-CN 26000/g Spectra Stable Isotopes 
 
 
 
 
 
 
P. SPOLAORE, C. JOANNIS-CASSAN, E. DURAN, A. ISAMBERT. Commercial applications of microalgae. Journal of Bioscience and 
Bioenginering, 101: pp. 87-96, 2006. 
 
 
TABLE 5. Present state of microalgal production (10, 48, 63, 69) 
Alga Annual 
production 
Producer country Application and product 
Arthrospira 3000 t dry 
weight 
China, India, USA, 
Myanmar, Japan 
Human and animal nutrition, 
cosmetics, phycobiliproteins 
Chlorella 2000 t dry 
weight 
Taiwan, Germany, 
Japan 
Human nutrition, 
aquaculture, cosmetics 
Dunaliella salina 1200 t dry 
weight 
Australia, Israel, 
USA, China 
Human nutrition, cosmetics, 
β-carotene 
Aphanizomenon flos-
aquae 
500 t dry 
weight 
USA Human nutrition 
Haematococcus 
pluvialis 
300 t dry 
weight 
USA, India, Israel Aquaculture, astaxanthin 
Crypthecodinium 
cohnii 
240 t DHA oil USA DHA oil 
Shizochytrium 10 t DHA oil USA DHA oil 
 
